T Pirttilä1, S Vanhatalo, U Turpeinen, R Riikonen. 1. Department of Neurology, Kuopio University Hospital and University of Kuopio, Kuopio, Finland. tuula.pirttila@kuh.fi
Abstract
OBJECTIVES: Many studies have shown that nitric oxide (NO) and growth factors including insulin growth factors (IGFs) may be involved in the pathogenesis of multiple sclerosis (MS) and neurodegenerative diseases. Our previous studies suggested a relationship between cerebrospinal fluid (CSF) NO metabolites (nitrates and nitrites, NN(x)) and IGF-1 in patients with progressive encephalopathy, hypsarrhythmia and optic atrophy syndrome. MATERIAL AND METHODS: We examined CSF concentrations of NN(x), IGF-1 and IGF binding protein-2 (IGFBP-2) in 25 controls, 14 patients with MS and 14 patients with amyotrophic lateralis sclerosis (ALS). RESULTS: There were no significant differences in CSF levels of NN(x), IGF-1 or IGFBP-2 between the groups. CSF IGFBP-2 concentrations correlated significantly with age in controls, which may reflect age-related changes in the blood-brain barrier function. CONCLUSION: Upregulation of the production of NO and IGF-1 in the brain or spinal cord does not influence CSF levels of these molecules in MS or ALS.
OBJECTIVES: Many studies have shown that nitric oxide (NO) and growth factors including insulin growth factors (IGFs) may be involved in the pathogenesis of multiple sclerosis (MS) and neurodegenerative diseases. Our previous studies suggested a relationship between cerebrospinal fluid (CSF) NO metabolites (nitrates and nitrites, NN(x)) and IGF-1 in patients with progressive encephalopathy, hypsarrhythmia and optic atrophy syndrome. MATERIAL AND METHODS: We examined CSF concentrations of NN(x), IGF-1 and IGF binding protein-2 (IGFBP-2) in 25 controls, 14 patients with MS and 14 patients with amyotrophic lateralis sclerosis (ALS). RESULTS: There were no significant differences in CSF levels of NN(x), IGF-1 or IGFBP-2 between the groups. CSF IGFBP-2 concentrations correlated significantly with age in controls, which may reflect age-related changes in the blood-brain barrier function. CONCLUSION: Upregulation of the production of NO and IGF-1 in the brain or spinal cord does not influence CSF levels of these molecules in MS or ALS.
Authors: Sung Eun Sim; Yoon Hee Chung; Ji Hoon Jeong; Sin Weon Yun; Hyoun-Sub Lim; Daejin Kim; Sung Su Kim; Won Bok Lee; Choong Ik Cha Journal: J Mol Histol Date: 2009-05-26 Impact factor: 2.611
Authors: Svitlana Garbuzova-Davis; Samuel Saporta; Edward Haller; Irina Kolomey; Steven P Bennett; Huntington Potter; Paul R Sanberg Journal: PLoS One Date: 2007-11-21 Impact factor: 3.240
Authors: J Saul; E Hutchins; R Reiman; M Saul; L W Ostrow; B T Harris; K Van Keuren-Jensen; R Bowser; N Bakkar Journal: Acta Neuropathol Commun Date: 2020-06-26 Impact factor: 7.801
Authors: Ethan A Winkler; Jesse D Sengillo; John S Sullivan; Jenny S Henkel; Stanley H Appel; Berislav V Zlokovic Journal: Acta Neuropathol Date: 2012-09-01 Impact factor: 17.088